Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 10, 2012, Pages 1629-1634

  Wang, Zhen Kai ^a   Liu, Jiong ^a   Liu, Chan ^a   Wang, Fang Yu ^a   Chen, Chun Yan ^a   Zhang, Xin Hua ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Adenomatous polyposis coli; Gastric adenomas; Gene mutation; Helicobacter pylori; Hypermethylation

Indexed keywords

APC PROTEIN; BETA CATENIN; GENOMIC DNA; WNT PROTEIN;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH GRADE GASTRIC ADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOW GRADE STOMACH ADENOMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SCORING SYSTEM; STOMACH ADENOMA; TUMOR VOLUME; WNT SIGNALING PATHWAY;

EID: 84866545563     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07219.x     Document Type: Article

References (28)

1. Tsujitani S, Furusawa M, Hayashi I. Morphological factors aid in therapeutic decisions concerning gastric adenomas. Hepatogastroenterology 1992; 39: 56-8.
2. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-2.
3. Orford K, Crockett C, Jenson JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem. 1997; 272: 24735-8.
4. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am. J. Pathol. 2000; 157: 747-54.
5. Maekita T, Nakazawa K, Mihara M etal. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006; 12: 989-95.
6. Schlemper RJ, Riddell RH, Kato Y etal. The Vienna classification of Gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
7. Palii SS, Robertson KD. Epigenetic control of tumor suppression. Crit. Rev. Eukaryot. Gene Expr. 2007; 17: 295-316.
8. Dixon MF, Genta RM, Yardley JH etal. Classification and grading of gastritis. Am. J. Surg. Pathol. 1996; 20: 1161-81.
9. Ebert MP, Yu J, Hoffmann J etal. Loss of beta-catenin expression in metastatic gastric cancer. J. Clin. Oncol. 2003; 21: 1708-14.
10. Chen J, Rocken C, Lofton-Day C etal. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. Carcinogenesis 2005; 26: 37-43.
11. Iwao K, Nakamori S, Kameyama M etal. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 1998; 58: 1021-6.
12. Esteller M, Sparks A, Toyota M etal. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000; 60: 4366-71.
13. Virmani AK, Rathi A, Sathyanarayana UG etal. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res. 2001; 7: 1998-2004.
14. Rocco A, Caruso R, Toracchio S etal. Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. Ann. Oncol. 2006; 17: 103-8.
15. Sasako M, Mann GB, van-de-Velde CJ, Hirohashi S, Yoshida S. Report of the Eleventh International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Gastric Cancer. Jpn J. Clin. Oncol. 1998; 28: 443-9.
16. Sporn MB, Liby KT. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat. Clin. Pract. Oncol. 2005; 2: 518-25.
17. Saito D. Gastric premalignancy and cancer screening in high-risk patients. Am. J. Gastroenterol. 1996; 91: 839-43.
18. Pisano R, Llorens P, Backhouse C, Palma M. Anatomopathological study of 86 gastric adenomas: Experience in 14years. Rev. Med. Chil. 1996; 124: 204-8.
19. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 1995; 27: 32-7.
20. Abraham SC, Montgomery EA, Singh VK, Yardley JH, Wu TT. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am. J. Surg. Pathol. 2002; 26: 1276-85.
21. Polakis P. Wnt signaling and cancer. Genes Dev. 2000; 14: 1837-51.
22. Kolligs FT, Nieman MT, Winer I etal. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell 2002; 1: 145-55.
23. Kim HS, Hong EK, Park SY, Kim WH, Lee HS. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Anticancer Res. 2003; 23: 2863-8.
24. Ignatov A, Bischoff J, Ignatov T etal. APC promoter hypermethylation is an early event in endometrial tumorigenesis. Cancer Sci. 2010; 101: 321-7.
25. Usadel H, Brabender J, Danenberg KD etal. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res. 2002; 62: 371-5.
26. Gotoda T, Saito D, Kondo H etal. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. J. Gastroenterol. 1999; 34 (Suppl. 11): 91-6.
27. Komoto K, Haruma K, Kamada T etal. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am. J. Gastroenterol. 1998; 93: 1271-6.
28. Perri F, Cotugno R, Piepoli A etal. Aberrant DNA methylation in nonneoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am. J. Gastroenterol. 2007; 102: 1361-71.